<bill session="117" type="h" number="1026" updated="2023-01-11T13:47:25Z">
  <state datetime="2021-02-11">REFERRED</state>
  <status>
    <introduced datetime="2021-02-11"/>
  </status>
  <introduced datetime="2021-02-11"/>
  <titles>
    <title type="display">LABEL Opioids Act</title>
    <title type="official" as="introduced">To amend the Controlled Substances Act to require dispensers of certain opioids and opiates to affix on the container or package thereof a clear, concise warning that the opioid or opiate can cause dependence, addiction, and overdose, and for other purposes.</title>
    <title type="short" as="introduced">LABEL Opioids Act</title>
    <title type="short" as="introduced">Lessening Addiction By Enhancing Labeling Opioids Act of 2021</title>
  </titles>
  <sponsor bioguide_id="S001211"/>
  <cosponsors>
    <cosponsor bioguide_id="B001298" joined="2022-03-15"/>
    <cosponsor bioguide_id="H001090" joined="2022-03-01"/>
    <cosponsor bioguide_id="H001081" joined="2021-03-03"/>
    <cosponsor bioguide_id="J000298" joined="2022-06-14"/>
    <cosponsor bioguide_id="M001135" joined="2022-06-23"/>
    <cosponsor bioguide_id="O000171" joined="2022-06-07"/>
    <cosponsor bioguide_id="S001205" joined="2021-02-22"/>
    <cosponsor bioguide_id="V000133" joined="2021-03-02"/>
  </cosponsors>
  <actions>
    <action datetime="2021-02-11">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-02-11" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-02-11">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-02-12">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2021-04-28">
      <text>Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU08" name="House Judiciary" subcommittee="Crime and Federal Government Surveillance" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="s" number="2353" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Consumer affairs"/>
    <term name="Criminal justice information and records"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health information and medical records"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2021-07-14T18:07:37Z" status="Introduced in House">Lessening Addiction By Enhancing Labeling Opioids Act of 2021 or the LABEL Opioids Act

This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose. A registrant (e.g., a pharmacist) who dispenses an opioid in violation of the labeling requirement is subject to penalties.</summary>
</bill>
